Identification of target proteins for breast cancer genetic risk loci and blood risk biomarkers in a large study by integrating genomic and proteomic data

Abstract

AbstractGenome‐wide association studies (GWAS) have identified around 200 loci associated with breast cancer risk. However, protein targets for these loci remain largely unknown. Identifying protein targets and biomarkers can improve the understanding of cancer biology and etiology and identify high‐risk individuals for cancer prevention. In this study, we investigated genetically predicted levels of 1142 circulating proteins with breast cancer risk in 133 384 cases and 113 789 controls of European ancestry included in the Breast Cancer Association Consortium (BCAC). We identified 22 blood protein biomarkers associated with the risk of overall breast cancer at a false discovery rate (FDR) <0.05, including nine proteins encoded by genes located at least 500 kb away from previously reported risk variants for breast cancer. Analyses focusing on 124 encoding genes located at GWAS‐identified breast cancer risk loci found 20 proteins associated with overall breast cancer risk and one protein associated with triple‐negative breast cancer risk at FDR <0.05. Adjustment for the GWAS‐identified risk variants significantly attenuated the association for 13 of these proteins, suggesting that these proteins may be the targets of these GWAS‐identified risk loci. The identified proteins are involved in various biological processes, including glutathione conjugation, STAT5 signaling and NF‐κB signaling pathways. Our study identified novel protein targets and risk biomarkers for breast cancer risk.